FDA Brief

Warning letters Drugs

FDA warning letter to

Ketdaxandrugs / www.ketdaxandrugs.org

High riskIssued Jun 23Posted Jul 7Center for Drug Evaluation and Research (CDER)

FDA warned Ketdaxandrugs it sells unapproved, misbranded ketamine "KETAMINE CRYSTAL" online without prescriptions to U.S. consumers.

What happened

FDA reviewed the website www.ketdaxandrugs.org (FEI 3043544188) on February 26, 2026; this was a website review, not an inspection. FDA found the site offering ketamine marketed as "KETAMINE CRYSTAL" for human use with no FDA-approved application, no adequate directions for use, and without requiring a prescription. FDA noted that approved ketamine is an injectable controlled substance, and that approved esketamine (SPRAVATO) carries a boxed warning and is sold only through a restricted safety program (REMS).

What FDA found

  1. The company sold ketamine as a new drug without an FDA-approved application.

    FD&C Act sections 301(d) and 505(a) (21 U.S.C. 331(d), 355(a))
  2. The product's labeling does not give adequate directions for use.

    FD&C Act section 502(f)(1) (21 U.S.C. 352(f)(1))
  3. The product is not exempt from the directions requirement because it is not approved in the United States.

    21 CFR 201.115(a)
  4. The company offers a prescription drug without requiring a prescription, so the drug is misbranded while held for sale.

    FD&C Act sections 503(b)(1) and 301(k) (21 U.S.C. 353(b)(1), 331(k))
  5. Website claims show the product is intended for human use as a drug.

    21 CFR 201.128

What FDA wants

FDA asks the company to stop offering any unapproved and misbranded drugs for sale to U.S. consumers. It must send a written response within 15 business days of receiving the letter, listing the corrections made, steps to prevent repeat violations, and supporting documents, citing reference number MARCS-CMS 725155.

Who should pay attention

  • online sellers and telehealth sites offering ketamine products
  • clinics and compounding pharmacies marketing ketamine
  • consumers buying prescription drugs from unverified websites

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. New Green Nutrition Inc.

    FDA says New Green Nutrition sold unapproved drugs online, and its Qu Feng Huo Luo Dan contained hidden dexamethasone.

    High risk
  2. Ong Tien USA LLC

    FDA warned Ong Tien USA LLC that its herbal joint products are unapproved drugs and one contained hidden piroxicam and dexamethasone.

    High risk
  3. Bella’s Nutri Shop Inc.

    Bella’s Nutri Shop sells “Tawon Liar” as an unapproved drug with hidden dexamethasone, tapentadol, and meloxicam.

    High risk
  4. Phuoc Loc Tho Herbals, Inc.

    FDA warned Phuoc Loc Tho Herbals that its herbal products are unapproved new drugs marketed with disease claims.

    High risk